Dr Reddy's plans scale up in Brazil and China; Japan on the radar
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories expects to scale up operations in some large emerging markets such as China and Brazil, as part of its strategy to pursue "profitable growth".